Pelthos Therapeutics Inc.
PTHS
$19.81-3.39%
End of day · as of Oct 13, 2026, 2:00 AM ET
Mkt cap
$94.75M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$16.80M
EPS (TTM)
$-28.55
Gross Margin (FY2025)
76.25%
Profit Margin (FY2025)
-257.93%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
Use this PTHS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PTHS income, balance, and cash tables.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company in the Healthcare sector.
Latest cached Pelthos Therapeutics Inc. (PTHS) revenue for Dec 31, 2025 was $16.8M. Net income was -$43.3M. Statements: https://lician.com/financials/pths
Pelthos Therapeutics Inc. (PTHS) market capitalization is $94.7M on the latest cached snapshot.
Pelthos Therapeutics Inc. (PTHS) cached previous close $20.50; day range $19.81 – $20.36; volume 56,281. Session quote: https://lician.com/quote/pths
Pelthos Therapeutics Inc. (PTHS) latest cached earnings event is "PTHS earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached PTHS filing is 8-K · Oct 1, 2026. Filings: https://lician.com/sec/pths